EUR 8.4
(-1.19%)
Year | Eps | Eps Growth |
---|---|---|
2023 | - EUR | -100.0% |
2022 | 0.38 EUR | 3492.86% |
2021 | -0.01 EUR | -100.59% |
2020 | 1.90 EUR | 1827.27% |
2019 | -0.11 EUR | 89.11% |
2018 | -1.01 EUR | 57.2% |
2017 | -2.36 EUR | -11.32% |
2016 | -2.12 EUR | -30.06% |
2015 | -1.63 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | - EUR | 100.0% |
2024 Q2 | - EUR | 0.0% |
2023 Q2 | 0.02 EUR | 0.0% |
2023 Q1 | 0.02 EUR | -88.24% |
2023 Q4 | -0.03 EUR | 0.0% |
2023 Q3 | -0.03 EUR | -245.5% |
2023 FY | - EUR | -100.0% |
2022 Q1 | 0.02 EUR | 0.0% |
2022 Q2 | 0.02 EUR | 0.0% |
2022 Q3 | 0.17 EUR | 865.91% |
2022 Q4 | 0.17 EUR | 0.0% |
2022 FY | - EUR | 3492.86% |
2021 Q2 | 0.00 EUR | 0.0% |
2021 FY | - EUR | -100.59% |
2021 Q1 | 0.00 EUR | -99.78% |
2020 Q1 | -0.03 EUR | 67.3% |
2020 FY | - EUR | 1827.27% |
2020 Q4 | 1.00 EUR | 3.09% |
2020 Q2 | -0.03 EUR | 0.0% |
2020 Q3 | 0.97 EUR | 3066.36% |
2019 Q1 | 0.04 EUR | 115.38% |
2019 Q4 | -0.10 EUR | 0.0% |
2019 Q2 | 0.04 EUR | 0.0% |
2019 FY | - EUR | 89.11% |
2019 Q3 | -0.10 EUR | -350.0% |
2018 Q2 | -0.25 EUR | 0.0% |
2018 Q3 | -0.26 EUR | -4.0% |
2018 Q4 | -0.26 EUR | 0.0% |
2018 FY | - EUR | 57.2% |
2018 Q1 | -0.25 EUR | 70.24% |
2017 FY | - EUR | -11.32% |
2017 Q4 | -0.84 EUR | 0.0% |
2017 Q3 | -0.84 EUR | -154.55% |
2017 Q2 | -0.33 EUR | 0.0% |
2017 Q1 | -0.33 EUR | 45.0% |
2016 Q1 | -0.46 EUR | 16.36% |
2016 FY | - EUR | -30.06% |
2016 Q4 | -0.60 EUR | 0.0% |
2016 Q3 | -0.60 EUR | -30.43% |
2016 Q2 | -0.46 EUR | 0.0% |
2015 FY | - EUR | 0.0% |
2015 Q2 | -0.45 EUR | 0.0% |
2015 Q1 | -0.45 EUR | 0.0% |
2015 Q4 | -0.55 EUR | -22.22% |
2015 Q3 | -0.45 EUR | 0.0% |
2014 Q4 | -0.45 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AB Science S.A. | -0.20 EUR | 100.0% |
Boiron SA | 2.06 EUR | 100.0% |
Ipsen S.A. | 7.79 EUR | 100.0% |
Vetoquinol SA | 4.70 EUR | 100.0% |